BridgeMD
New treatment option for Placenta Accreta Spectrum
Official title Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
ClinicalTrials.gov ID: NCT06493968
What this study is testing
What is oxytocin?
oxytocin is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for placenta accreta spectrum.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Objectives: To evaluate the effect of oxytocin in reducing intraoperative blood loss in patients with PAS disorders planned for cesarean hysterectomy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 40, women only. Healthy volunteers may be eligible.
You may be able to join if
- Pregnancy of singleton living fetus
- Previous one or more cesarean sections
- Gestational age: \> 32 weeks
- The following ultrasound markers such as "loss of clear retroplacental translucency", "myometrial thinning", "abnormal lacunae", "irregular bladder...
- Preoperative hemoglobin more than 10 gm/dl
You likely can't join if
- Maternal medical disorders e.g.: coagulation defects, cardiac diseases etc.….
- Any known or reported hypersensitivity to the used medication.
- All cases with spontaneous placental separation at laparotomy.
- All patients undergoing conservative management of PAS.
- All cases which necessitate emergency termination.
See the full eligibility criteria
- Pregnancy of singleton living fetus
- Previous one or more cesarean sections
- Gestational age: \> 32 weeks
- The following ultrasound markers such as "loss of clear retroplacental translucency", "myometrial thinning", "abnormal lacunae", "irregular bladder wall", "utero-vesicalhypervascularity".
- Preoperative hemoglobin more than 10 gm/dl
- Cases with PAS that will undergoing CS Hysterectomy
- Maternal medical disorders e.g.: coagulation defects, cardiac diseases etc.….
- Any known or reported hypersensitivity to the used medication.
- All cases with spontaneous placental separation at laparotomy.
- All patients undergoing conservative management of PAS.
- All cases which necessitate emergency termination.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.